476 related articles for article (PubMed ID: 14624371)
21. Polymorphisms in the CCR5 promoter region influence disease progression in perinatally human immunodeficiency virus type 1-infected children.
Ometto L; Bertorelle R; Mainardi M; Zanchetta M; Tognazzo S; Rampon O; Ruga E; Chieco-Bianchi L; De Rossi A
J Infect Dis; 2001 Mar; 183(5):814-8. PubMed ID: 11181160
[TBL] [Abstract][Full Text] [Related]
22. Adverse effect of the CCR5 promoter -2459A allele on HIV-1 disease progression.
Knudsen TB; Kristiansen TB; Katzenstein TL; Eugen-Olsen J;
J Med Virol; 2001 Nov; 65(3):441-4. PubMed ID: 11596075
[TBL] [Abstract][Full Text] [Related]
23. [Variant genotyping of CCR2-64I, SDF1-3' A and CCR5Delta32 in HIV-1 infected Chinese long-term nonprogressors].
Wang SX; Shang H; Han XX; Zhang ZN; Wang YN; Zhang M; Jiang YJ; Liu J; Su YL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Mar; 20(1):16-9. PubMed ID: 16642210
[TBL] [Abstract][Full Text] [Related]
24. Analysis of genetic polymorphisms in CCR5, CCR2, stromal cell-derived factor-1, RANTES, and dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin in seronegative individuals repeatedly exposed to HIV-1.
Liu H; Hwangbo Y; Holte S; Lee J; Wang C; Kaupp N; Zhu H; Celum C; Corey L; McElrath MJ; Zhu T
J Infect Dis; 2004 Sep; 190(6):1055-8. PubMed ID: 15319853
[TBL] [Abstract][Full Text] [Related]
25. [Polymorphisms of chemokine receptor alleles influencing genetic susceptibility to HIV-1 infection in Mongolia population in China].
Du Q; Wang F; Hong W; Liu M; Jin L; Shi H; Lei Z; E E
Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Dec; 21(6):413-6. PubMed ID: 11860823
[TBL] [Abstract][Full Text] [Related]
26. Stromal cell-derived factor 1 (SDF1) genetic polymorphism in a sample of healthy individuals, seronegative individuals exposed to human immunodeficiency virus type 1 (HIV-1) and patients infected with HIV-1 from the Brazilian population.
Reiche EM; Watanabe MA; Bonametti AM; Morimoto HK; Morimoto AA; Wiechmann SL; Matsuo T; Miranda HC; Reiche FV; Oliveira KB
Int J Immunogenet; 2006 Apr; 33(2):127-33. PubMed ID: 16611258
[TBL] [Abstract][Full Text] [Related]
27. Genetic polymorphisms in CX3CR1 predict HIV-1 disease progression in children independently of CD4+ lymphocyte count and HIV-1 RNA load.
Singh KK; Hughes MD; Chen J; Spector SA
J Infect Dis; 2005 Jun; 191(11):1971-80. PubMed ID: 15871132
[TBL] [Abstract][Full Text] [Related]
28. CCR2-64I polymorphism, syncytium-inducing human immunodeficiency virus strains, and disease progression.
Vicenzi E; Ghezzi S; Brambilla A; Sheppard HW; Lazzarin A; Poli G; Michael NL
J Infect Dis; 2000 Nov; 182(5):1579-80. PubMed ID: 11023492
[No Abstract] [Full Text] [Related]
29. Distinctive effects of CCR5, CCR2, and SDF1 genetic polymorphisms in AIDS progression.
Hendel H; Hénon N; Lebuanec H; Lachgar A; Poncelet H; Caillat-Zucman S; Winkler CA; Smith MW; Kenefic L; O'Brien S; Lu W; Andrieu JM; Zagury D; Schächter F; Rappaport J; Zagury JF
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(4):381-6. PubMed ID: 9833747
[TBL] [Abstract][Full Text] [Related]
30. Allelic variants of human beta-chemokine receptor 5 (CCR5) promoter: evolutionary relationships and predictable associations with HIV-1 disease progression.
Tang J; Rivers C; Karita E; Costello C; Allen S; Fultz PN; Schoenbaum EE; Kaslow RA
Genes Immun; 1999 Sep; 1(1):20-7. PubMed ID: 11197301
[TBL] [Abstract][Full Text] [Related]
31. No evidence for an effect of the CCR5 delta32/+ and CCR2b 64I/+ mutations on human immunodeficiency virus (HIV)-1 disease progression among HIV-1-infected injecting drug users.
Schinkel J; Langendam MW; Coutinho RA; Krol A; Brouwer M; Schuitemaker H
J Infect Dis; 1999 Apr; 179(4):825-31. PubMed ID: 10068577
[TBL] [Abstract][Full Text] [Related]
32. The frequency of CCR5Delta32 and CCR2-64I in southern Iranian normal population.
Gharagozloo M; Doroudchi M; Farjadian S; Pezeshki AM; Ghaderi A
Immunol Lett; 2005 Jan; 96(2):277-81. PubMed ID: 15585333
[TBL] [Abstract][Full Text] [Related]
33. Genetic variations in CC chemokine receptors and hypertension.
Zhang M; Ardlie K; Wacholder S; Welch R; Chanock S; O'Brien TR
Am J Hypertens; 2006 Jan; 19(1):67-72. PubMed ID: 16461193
[TBL] [Abstract][Full Text] [Related]
34. Do human polyoma viruses and human immunodeficiency virus share common co-receptors?
Borissov K; Tsekov I; Gavazova R; Kalvatchev Z; Argirova R
J Med Virol; 2010 Jan; 82(1):8-13. PubMed ID: 19950235
[TBL] [Abstract][Full Text] [Related]
35. Stromal cell-derived factor (SDF) 1-3'A polymorphism may play a role in resistance to HIV-1 infection in seronegative high-risk Thais.
Tiensiwakul P
Intervirology; 2004; 47(2):87-92. PubMed ID: 15192272
[TBL] [Abstract][Full Text] [Related]
36. Chemokine receptor gene polymorphisms and risk of human T lymphotropic virus type I infection in Jamaica.
Hisada M; Lal RB; Masciotra S; Rudolph DL; Martin MP; Carrington M; Wilks RJ; Manns A
J Infect Dis; 2002 May; 185(9):1351-4. PubMed ID: 12001056
[TBL] [Abstract][Full Text] [Related]
37. Analysis of CCR5, CCR2, SDF1 and RANTES gene polymorphisms in subjects with HIV-related PML and not determined leukoencephalopathy.
Guerini FR; Delbue S; Zanzottera M; Agliardi C; Saresella M; Mancuso R; Maserati R; Marchioni E; Gori A; Ferrante P
Biomed Pharmacother; 2008 Jan; 62(1):26-30. PubMed ID: 17560067
[TBL] [Abstract][Full Text] [Related]
38. Analysis of CCR5, CCR2, CX3CR1, and SDF1 polymorphisms in HIV-positive treated patients: impact on response to HAART and on peripheral T lymphocyte counts.
Puissant B; Roubinet F; Massip P; Sandres-Saune K; Apoil PA; Abbal M; Pasquier C; Izopet J; Blancher A
AIDS Res Hum Retroviruses; 2006 Feb; 22(2):153-62. PubMed ID: 16478397
[TBL] [Abstract][Full Text] [Related]
39. Limited protective effect of the CCR5Delta32/CCR5Delta32 genotype on human immunodeficiency virus infection incidence in a cohort of patients with hemophilia and selection for genotypic X4 virus.
Iversen AK; Christiansen CB; Attermann J; Eugen-Olsen J; Schulman S; Berntorp E; Ingerslev J; Fugger L; Scheibel E; Tengborn L; Gerstoft J; Dickmeiss E; Svejgaard A; Skinhøj P
J Infect Dis; 2003 Jan; 187(2):215-25. PubMed ID: 12552446
[TBL] [Abstract][Full Text] [Related]
40. CC chemokine receptor 5 delta32 and CC chemokine receptor 2 64I polymorphisms do not influence the virologic and immunologic response to antiretroviral combination therapy in human immunodeficiency virus type 1-infected patients.
Wit FW; van Rij RP; Weverling GJ; Lange JM; Schuitemaker H
J Infect Dis; 2002 Dec; 186(12):1726-32. PubMed ID: 12447757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
